Where Patients, Doctors

and Biotechnology Meet. 

About us. 

"Biotechnology is continuously improving our ability to diagnose diseases". 

Noel Silva, CEO.

The in vitro diagnostics (IVD) market (a subset of the overall medical technology market — which focuses on molecular diagnostics for conditions like infectious diseases, chronic diseases, sexually-transmitted diseases (STDs), oncology, and genetic testing) was valued at almost $50 billion in 2012 and expected to reach nearly $70 billion by 2017 according to a report by Research and Markets.

Identify novel global Allergy and Immunology in vitro diagnostic opportunities while lowering the cost of health care and provide faster and better diagnostic services to the physician community. 

To be the partner of choice for development and commercialization of novel diagnostic assays.

Quality Policy     

CDG Biotech Corp is focused on generate superb customer satisfaction by providing in vitro diagnostics products that will meet our clients’ needs.
As such, we have implemented a Quality Management System which complies with internal and regulatory requirements.
Our organization is focus on continuous improvement as its strategic imperative.
We periodically review our Quality Management System to ensure effectiveness and compliance with current standards according to the guidelines established by regulatory agencies.

We have state of the art facilities in Westlake Village, CA.